| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YJMCC.2019.04.003 |
| P698 | PubMed publication ID | 30978343 |
| P2093 | author name string | Kate L Weeks | |
| Rushita A Bagchi | |||
| P2860 | cites work | HDAC inhibition helps post-MI healing by modulating macrophage polarization. | Q52717737 |
| HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury. | Q52719352 | ||
| Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts. | Q52793543 | ||
| Novel Histone Deacetylase Inhibitor Modulates Cardiac Peroxisome Proliferator-Activated Receptors and Inflammatory Cytokines in Heart Failure. | Q55044891 | ||
| Histone Deacetylase 11 Is an ε-N-Myristoyllysine Hydrolase | Q57175323 | ||
| Sirtuins and NAD in the Development and Treatment of Metabolic and Cardiovascular Diseases | Q57822214 | ||
| HDAC11 suppresses the thermogenic program of adipose tissue via BRD2 | Q58792327 | ||
| Effect of recombinant human insulin-like growth factor-I on expression of glucose transporters, GLUT 2 and GLUT 4, in streptozotocin-diabetic rat | Q77518604 | ||
| Inhibition of histone deacetylase on ventricular remodeling in infarcted rats | Q80076073 | ||
| HDAC6 Promotes Cardiac Fibrosis Progression through Suppressing RASSF1A Expression | Q86246870 | ||
| Maternal high fat diet induces early cardiac hypertrophy and alters cardiac metabolism in Sprague Dawley rat offspring | Q88461337 | ||
| Programming and Regulation of Metabolic Homeostasis by HDAC11 | Q89353095 | ||
| Three proteins define a class of human histone deacetylases related to yeast Hda1p | Q22009464 | ||
| Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor | Q22253464 | ||
| Histone deacetylases specifically down-regulate p53-dependent gene activation | Q22253949 | ||
| Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization | Q22254367 | ||
| Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR | Q24292197 | ||
| Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain | Q24292353 | ||
| CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy | Q24293269 | ||
| HDAC6 is a microtubule-associated deacetylase | Q24298013 | ||
| AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5 | Q24306179 | ||
| Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation | Q24307379 | ||
| HDAC4 deacetylase associates with and represses the MEF2 transcription factor | Q24534407 | ||
| Histone deacetylases (HDACs): characterization of the classical HDAC family | Q24535587 | ||
| Identification of a signal-responsive nuclear export sequence in class II histone deacetylases | Q24550848 | ||
| Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5 | Q24561772 | ||
| Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3 | Q24648290 | ||
| Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice | Q24650710 | ||
| Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2 | Q24673733 | ||
| Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases | Q24682791 | ||
| Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop | Q24682945 | ||
| Lysine acetylation targets protein complexes and co-regulates major cellular functions | Q27860589 | ||
| Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure | Q27865207 | ||
| Glucose Transporters in Cardiac Metabolism and Hypertrophy | Q28075863 | ||
| Deacetylation of p53 modulates its effect on cell growth and apoptosis | Q28138967 | ||
| Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70 | Q28214548 | ||
| Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy | Q28219383 | ||
| Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family | Q28252866 | ||
| A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p | Q28276243 | ||
| Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity | Q28508698 | ||
| Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10 | Q28509194 | ||
| Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development | Q28592216 | ||
| Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4 | Q28592681 | ||
| Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study | Q29614968 | ||
| EED orchestration of heart maturation through interaction with HDACs is H3K27me3-independent. | Q33591193 | ||
| Histone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model | Q33599573 | ||
| Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion | Q33714350 | ||
| Histone deacetylase 10 structure and molecular function as a polyamine deacetylase | Q33753801 | ||
| HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation | Q33891516 | ||
| HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling | Q33913127 | ||
| Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition | Q33917016 | ||
| Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy | Q33929939 | ||
| Left ventricular hypertrophy: pathogenesis, detection, and prognosis | Q33977917 | ||
| Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes | Q33998649 | ||
| Controlling the double helix | Q34172152 | ||
| Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). | Q34206633 | ||
| Class II histone deacetylases limit GLUT4 gene expression during adipocyte differentiation | Q34452611 | ||
| Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation | Q34540285 | ||
| Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5 | Q34761571 | ||
| Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation | Q34788395 | ||
| Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension | Q35040811 | ||
| Histone deacetylase 9 is a negative regulator of adipogenic differentiation | Q35145068 | ||
| Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation | Q35338684 | ||
| Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms. | Q35517710 | ||
| Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction | Q35671740 | ||
| Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis | Q35847709 | ||
| Histone Deacetylase 3 (HDAC3)-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity | Q35860651 | ||
| Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility | Q35893654 | ||
| Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice | Q35922922 | ||
| Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases | Q36141408 | ||
| Essential Nonredundant Function of the Catalytic Activity of Histone Deacetylase 2 in Mouse Development | Q36481113 | ||
| Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats | Q37239770 | ||
| HDAC9 knockout mice are protected from adipose tissue dysfunction and systemic metabolic disease during high-fat feeding | Q37403326 | ||
| Investigating the selectivity of metalloenzyme inhibitors | Q37432771 | ||
| Molecular mechanisms of diabetic cardiomyopathy. | Q37672583 | ||
| Erasers of histone acetylation: the histone deacetylase enzymes | Q37673993 | ||
| Myocardial fatty acid metabolism in health and disease | Q37677921 | ||
| Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. | Q37700043 | ||
| The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives | Q37953791 | ||
| Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs. | Q38196176 | ||
| Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes | Q38209594 | ||
| Global and regional patterns in cardiovascular mortality from 1990 to 2013. | Q38616787 | ||
| Multi-Cellular Transcriptional Analysis of Mammalian Heart Regeneration | Q38667300 | ||
| Inflammatory processes in cardiovascular disease: a route to targeted therapies | Q38788685 | ||
| Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice | Q38982581 | ||
| Histone deacetylase 5 regulates glucose uptake and insulin action in muscle cells | Q39275916 | ||
| Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure | Q39951451 | ||
| The CRM1 nuclear export receptor controls pathological cardiac gene expression | Q40586178 | ||
| Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation | Q41150386 | ||
| β-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α-PP2A-Mediated Dephosphorylation. | Q41165926 | ||
| Regulation of cardiac stress signaling by protein kinase d1. | Q41496270 | ||
| Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
| miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8. | Q41693992 | ||
| GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes | Q41908985 | ||
| Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling | Q41919774 | ||
| HDAC4 controls histone methylation in response to elevated cardiac load | Q41992090 | ||
| Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice | Q43012174 | ||
| Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats. | Q43140361 | ||
| Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure | Q43523644 | ||
| Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle | Q44865473 | ||
| Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation. | Q45997206 | ||
| Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice | Q46429786 | ||
| The use of diversity profiling to characterize chemical modulators of the histone deacetylases | Q46613064 | ||
| Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding | Q46870302 | ||
| A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway. | Q47567230 | ||
| Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes | Q48034669 | ||
| Histone Deacetylase 11 Is a Fatty-Acid Deacylase | Q48237457 | ||
| Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy | Q49955216 | ||
| Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity | Q49960457 | ||
| Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism. | Q50045909 | ||
| P304 | page(s) | 151-159 | |
| P577 | publication date | 2019-04-09 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | Histone deacetylases in cardiovascular and metabolic diseases | |
| P478 | volume | 130 |
| Q99708050 | CaMKII exacerbates heart failure progression by activating class I HDACs |
| Q92730996 | Pathogenic implications of dysregulated miRNAs in propionic acidemia related cardiomyopathy |
| Q92344377 | The Anti-Fibrotic Effects of CG-745, an HDAC Inhibitor, in Bleomycin and PHMG-Induced Mouse Models |
| Q91646371 | The Epac1 Protein: Pharmacological Modulators, Cardiac Signalosome and Pathophysiology |
Search more.